In addition, preventive i.n. administration reduced tumor onset through a mechanism linked partially with local and systemic NK cell recruitment, while s.c. therapeutic administration had no effect on tumor onset, instead reducing tumor size via a recruitment of IL-2 and CD3 but NK-cell-independent mechanism. This evidence concerns the gene IL2 and neoplasm.